7210 Wareham Drive, Tampa, FL 33647
May 22, 2024 A majority of patients taking weight loss drugs discontinue use of their medication before reaching a clinically meaningful health benefit, according to new research published May 21 by the Blue Cross Blue Shield Association. The study was conducted by Blue Health Intelligence and is based on national pharmacy and medical claims data from […]
Most weight loss drug users quit before seeing benefits Read More »
May 20, 2024 Medifast today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program. View the full release here: https://www.businesswire.com/news/home/20240520770526/en/ This will be an investment of up to $30 million in company-led marketing efforts. Medifast is committed
Medifast To Launch National Marketing Campaign Read More »
March 4, 2024 U.S. Weight Loss Market Now Worth $90 Billion, Obesity Drug Sales Soar March 4, 2024 Marketdata LLC has just published a new analysis of the weight loss market: “The U.S. Weight Loss Market: 2024 Status Report & Forecast”, March 2024, 107 Pages Some findings: The total U.S. weight loss market is estimated
U.S. Weight Loss Market Worth $90 Billion, Boosted by Diet Drugs Read More »
Feb. 20, 2024 Medifast reported full-year and Q4 results on February 20, 2023. 2023 revenues came in at $1.07 billion. The company employed 41,100 active earning Optavia health coaches, who had quarterly earnings of $4,648 (or $18,592 on an annual rate). Management said that: “We are realigning our business to respond to the evolving dynamics
Medifast Reports Q4 and Full Year 2023 Results Read More »
January 4, 2024 The history of weight loss drugs in the U.S. is filled with meds that were taken off the market due to nasty side effects, going back to the phen/fen crisis of 1997. Many more followed (Belviq, Qsymia, Taranabant, Acomplia) . These side effects did not emerge until years after entering the market
Semaglutide Boom – The Beginning of a Decline? New FDA Report Read More »
Aug. 8, 2023 Second quarter 2023 revenue decreased 34.7% to $296.2 million from $453.3 million for the second quarter of 2022, primarily driven by a decrease in the number of active earning OPTAVIA Coaches and the decline in the productivity per active earning OPTAVIA Coach. The average revenue per active earning OPTAVIA Coach was $5,578, compared to $6,667 for the second quarter last year, a
Medifast Reports Q2 Results Read More »
May 1, 2023 According to management: “We’re pleased to see revenue and operating income both ahead of expectations in the quarter, as we continue to adjust to the changing dynamics of the business environment,” said Dan Chard, Medifast’s Chairman & Chief Executive Officer. “Sustainable long-term growth is at the core of our focus, and we are
Medifast Reports 1st Quarter Results Read More »
May 8, 2023 It’s official, Jenny Craig has closed its doors, and will not be transitioning to an e-commerce model, as it had indicated last week. Operations in Australia, however, will remain open. Last week, Jenny Craig had alerted employees to potential mass layoffs as it begins “winding down physical operations” and hunts for a
Jenny Craig Out of Business Read More »
April 25, 2023 In case you haven’t noticed, literally hundreds of new market research firms have emerged from India in the last 5-10 years, usually headquartered in Pune. Their websites look legit and professional, and they claim to be located in the United States. But, they are usually a one-person operation. Many of these companies
Beware Fake Weight Loss Research From India Read More »
April 19, 2023 We obtained some information regarding Noom’s participation in the medical weight loss arena. “…Noom Clinical is offered to adults (18+) that are over BMI 30 or, BMI 27 and above with obesity-related conditions. Individual eligibility for specific options is determined by our trained clinicians and overseen by our Chief of Medicine. With
Noom Is Testing Weight Loss Drugs Read More »